サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：mRNA合成原料の世界市場規模調査＆予測、製品別用途別エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1258080

mRNA合成原料の世界市場規模調査＆予測、製品別用途別エンドユーザー別、地域別分析、2022-2029年

Global mRNA Synthesis Raw Material Market Size study & Forecast, by Product by Application, by End-user and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
mRNA合成原料の世界市場規模調査＆予測、製品別用途別エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年04月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

mRNA合成原料の世界市場は、2021年に27億4,600万米ドルと評価され、予測期間2022-2029年に2.1％のCAGRで拡大すると予測されています。

DNAヌクレオチド配列からなるテンプレートを使用して、mRNAは核内の転写プロセスで作成されます。mRNAの適応性と柔軟性は、さまざまな慢性疾患や感染症に対する治療ワクチンや予防ワクチンを開発するための優れたプラットフォームとなっています。がんや慢性疾患の発生率の増加により、遺伝子治療に対する需要が高まっています。

遺伝子治療に対する需要の高まり、慢性疾患や感染症の増加により、mRNA合成・製造サービスの市場は今後数年間で大幅に増加すると予想されます。新しいmRNA療法の創出のために、多くの市場参入企業や研究機関に資金が提供されています。例えば、カナダ政府は2022年10月、mRNAワクチンの開発をさらに進めるため、コロンビア大学に1,110万米ドルの資金を提供しました。現在のCovid-2019パンデミックの間、多くの企業がコロナウイルスに対抗するためにmRNAワクチン技術を選択しました。同様に、2022年12月、ExPLoRNA Therapeuticsは、ビル＆メリンダ・ゲイツ財団から81万3578米ドルの資金を受け、mRNA技術の開発をさらに進めています。複数の市場プレイヤーの新たな関与が、市場をさらに牽引すると予想されます。mRNA合成原料の開発は、適応性があり、耐久性があり、合理的な価格の製造手順の欠如によって妨げられています。原材料の高コストが進歩の主な障害となっています。

mRNA合成原料の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカを含みます。mRNA合成に使用される原材料の市場は、北米が支配的でした。米国は、ファイザーやモデナなどの有名企業による大規模なmRNAワクチン製造施設が存在するため、業界リーダーとしての地位を維持すると予測されています。このため、この地域は予測期間中、優位性を維持するものと思われます。mRNA合成原料の世界市場では、研究開発費の増加、感染症の流行、最先端技術の迅速な導入により、最も成長が著しいと予想されるアジア太平洋地域が大きな割合を占めています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界およびセグメント別市場の推定・予測、2019年～2029年
    • mRNA合成原料市場、地域別、2019-2029年
    • mRNA合成原料市場、種類別、2019-2029年
    • mRNA合成原料市場、用途別、2019-2029年
    • mRNA合成原料市場、エンドユーザー別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 mRNA合成原料の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 世界のmRNA合成原料市場力学

  • mRNA合成原料市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • がんや慢性疾患の発生率の増加
      • 大手製薬会社の積極的な関与
    • 市場の課題
      • mRNA合成原料の高コスト化
    • 市場機会
      • COVID-19が生んだ必然
      • mRNAの利点は大きい

第4章 世界のmRNA合成原料市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 投資採用モデル
  • アナリストの提言と結論
  • 主な投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 mRNA合成原料の世界市場：タイプ別

  • マーケットスナップショット
  • mRNA合成原料の世界市場：種類別、性能別、潜在能力分析
  • mRNA合成原料の世界市場タイプ別推定・予測2019-2029
  • mRNA合成原料市場、サブセグメント別分析
    • キャッピングエージェント
    • ヌクレオチド
    • プラスミドDNA
    • その他

第7章 mRNA合成原料の世界市場：用途別

  • マーケットスナップショット
  • mRNA合成原料の世界市場：用途別、性能別- ポテンシャル分析
  • mRNA合成原料の世界市場推定・予測（用途別）2019-2029年版
  • mRNA合成原料市場、サブセグメント別分析
    • 治療薬の生産
    • ワクチン製造
    • その他

第8章 mRNA合成原料の世界市場：エンドユーザー別

  • マーケットスナップショット
  • mRNA合成原料の世界市場：エンドユーザー別、パフォーマンス-ポテンシャル分析
  • mRNA合成原料の世界市場エンドユーザー別推定・予測2019-2029
  • mRNA合成原料市場、サブセグメント別分析
    • バイオ医薬品・製薬会社
    • CRO・CMO
    • 学術・調査機関

第9章 mRNA合成原料の世界市場：地域別分析

  • mRNA合成原料市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • アプリケーション別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州のmRNA合成原料市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のmRNA合成原料市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ mRNA合成原料市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Pfizer Inc.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • タイプ概要
      • 最近の動向
    • Moderna, Inc.
    • BioNTech SE
    • Bayer AG
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • CureVac
    • Sarepta Therapeutics
    • Alnylam Pharmaceuticals
    • Ionis Pharmaceuticals

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global mRNA Synthesis Raw Material Market, report scope
  • TABLE 2. Global mRNA Synthesis Raw Material Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global mRNA Synthesis Raw Material Market estimates & forecasts byType2019-2029 (USD Million)
  • TABLE 4. Global mRNA synthesis raw material Market estimates & forecasts by Application2019-2029 (USD Million)
  • TABLE 5. Global mRNA synthesis raw material Market estimates & forecasts by End-user2019-2029 (USD Million)
  • TABLE 6. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 71. List of primary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global mRNA Synthesis Raw Material Market, research methodology
  • FIG 2. Global mRNA Synthesis Raw Material Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global mRNA Synthesis Raw Material Market, key trends 2021
  • FIG 5. Global mRNA Synthesis Raw Material Market, growth prospects 2022-2029
  • FIG 6. Global mRNA Synthesis Raw Material Market, porters 5 force model
  • FIG 7. Global mRNA Synthesis Raw Material Market, pest analysis
  • FIG 8. Global mRNA Synthesis Raw Material Market, value chain analysis
  • FIG 9. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global mRNA Synthesis Raw Material Market, regional snapshot 2019 & 2029
  • FIG 15. North America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 16. Europe mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 17. Asia pacific mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 18. Latin America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 19. Global mRNA Synthesis Raw Material Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global mRNA synthesis raw material market is valued at approximately USD2746 million in 2021and and is anticipated to expand at a compound annual growth rate (CAGR) of 2.1% over the forecast period 2022-2029.Using a template consisting of the DNA nucleotide sequence, mRNA is created by the transcription process in the nucleus.mRNA's adaptability and flexibility make it an excellent platform for developing therapeutic or preventive vaccines for a range of chronic and infectious diseases.The growing incidence of cancer and chronic disorders has raised the demand for gene treatments.

The market for mRNA synthesis and manufacturing services is expected to increase significantly over the next few years as a result of the rising demand for gene therapies, and the rise in chronic and infectious diseases. Funding is being provided for the creation of new mRNA therapies to numerous market participants and research institutions. For instance, the Canadian government provided USD 11.1 million in financing to the University of Columbia in October 2022 to further the development of mRNA vaccines. During the current Covid-2019 pandemic, many companies have chosen mRNA vaccine technology to combat coronavirus. Similarly, in December 2022, ExPLoRNA Therapeutics received USD 813,578 in funding from the Bill & Melinda Gates Foundation to further develop its mRNA technology. The emerging involvement of several market players is expected to drive the market further. The development of mRNA synthesis raw materials is hampered by a lack of adaptive, durable, and reasonably priced manufacturing procedures. The high cost of raw resources is the main impediment to progress.

The key regions considered for the Global mRNA synthesis raw material market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for raw materials used in mRNA synthesis. The United States is forecasted to keep up its position as the industry leader because ofthe existence of sizable mRNA vaccine production facilities by renowned companies such asPfizer and Moderna. Due to this, this region will maintain its dominance throughout the forecast period. A significant percentage of the global market for mRNA synthesis raw materials was owned by Asia Pacific, which is anticipated to be the fastest-growing region due to rising R&D expenditures, a growth in the prevalence of infectious diseases, and a quick uptake of cutting-edge technology.

Major market players included in this report are:

  • Pfizer Inc.
  • Moderna, Inc.
  • BioNTech SE
  • Bayer AG
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • CureVac
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Ionis Pharmaceuticals

Recent Developments in the Market:

  • In November 2022, The BASE and Sartorius formed an alliance to facilitate the sharing of development methodologies and strategies for various nucleic acid-based products. The collaboration will enable the efficient application of cutting-edge methods and analytical thinking to design and plan techniques for nucleic acid products.
  • Thermo Fisher Scientific unveiled a customised Dynabeads solution in October 2022, claiming that it aids in the synthesis and purification of mRNA for use in developing and manufacturing vaccines.
  • A final deal was signed by Sanofi in August 2021 to buy all of the outstanding shares of Translate Bio, a company that develops therapies for messenger RNA (mRNA). The purchase is a component of Sanofi's goal to hasten the application of mRNA technology in the creation of pharmaceuticals and vaccines.

Global mRNA synthesis raw material marketReport Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, application, end-user, region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Capping Agents
  • Nucleotides
  • Plasmid DNA
  • Others

By Application:

  • Therapeutics Production
  • Vaccine Production
  • Others

By End-user:

  • Biopharmaceutical & Pharmaceutical Companies CROs & CMOs
  • Academic & Research Institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. mRNA Synthesis Raw Material Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. mRNA Synthesis Raw Material Market, by Type,2019-2029 (USD Million)
    • 1.2.3. mRNA synthesis raw material Market, by Application, 2019-2029 (USD Million)
    • 1.2.4. mRNA synthesis raw material Market, by End-user, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global mRNA Synthesis Raw Material Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global mRNA Synthesis Raw Material Market Dynamics

  • 3.1. mRNA Synthesis Raw Material Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of cancer and chronic disorders
      • 3.1.1.2. Active Involvement of big pharma players
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of mRNA Synthesis Raw Material
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Necessity created by COVID-19
      • 3.1.3.2. Considerable benefits of mRNA

Chapter 4. Global mRNA Synthesis Raw Material Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global mRNA Synthesis Raw Material Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global mRNA Synthesis Raw Material Market by Type, Performance - Potential Analysis
  • 6.3. Global mRNA Synthesis Raw Material Market Estimates & Forecasts by Type 2019-2029 (USD Million)
  • 6.4. mRNA Synthesis Raw Material Market, Sub Segment Analysis
    • 6.4.1. Capping Agents
    • 6.4.2. Nucleotides
    • 6.4.3. Plasmid DNA
    • 6.4.4. Others

Chapter 7. Global mRNA synthesis raw material Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global mRNA synthesis raw material Market by Application, Performance - Potential Analysis
  • 7.3. Global mRNA synthesis raw material Market Estimates & Forecasts by Application2019-2029 (USD Million)
  • 7.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 7.4.1. Therapeutics Production
    • 7.4.2. Vaccine Production
    • 7.4.3. Others

Chapter 8. Global mRNA synthesis raw material Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global mRNA Synthesis Raw Material Market by End-user, Performance - Potential Analysis
  • 8.3. Global mRNA synthesis raw material Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
  • 8.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 8.4.1. Biopharmaceutical & Pharmaceutical Companies
    • 8.4.2. CROs & CMOs
    • 8.4.3. Academic & Research Institution

Chapter 9. Global mRNA Synthesis Raw Material Market, Regional Analysis

  • 9.1. mRNA Synthesis Raw Material Market, Regional Market Snapshot
  • 9.2. North America mRNA Synthesis Raw Material Market
    • 9.2.1. U.S.mRNA Synthesis Raw Material Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada mRNA Synthesis Raw Material Market
  • 9.3. Europe mRNA Synthesis Raw Material Market Snapshot
    • 9.3.1. U.K. mRNA Synthesis Raw Material Market
    • 9.3.2. Germany mRNA Synthesis Raw Material Market
    • 9.3.3. France mRNA Synthesis Raw Material Market
    • 9.3.4. Spain mRNA Synthesis Raw Material Market
    • 9.3.5. Italy mRNA Synthesis Raw Material Market
    • 9.3.6. Rest of Europe mRNA Synthesis Raw Material Market
  • 9.4. Asia-Pacific mRNA Synthesis Raw Material Market Snapshot
    • 9.4.1. China mRNA Synthesis Raw Material Market
    • 9.4.2. India mRNA Synthesis Raw Material Market
    • 9.4.3. Japan mRNA Synthesis Raw Material Market
    • 9.4.4. Australia mRNA Synthesis Raw Material Market
    • 9.4.5. South Korea mRNA Synthesis Raw Material Market
    • 9.4.6. Rest of Asia Pacific mRNA Synthesis Raw Material Market
  • 9.5. Latin America mRNA Synthesis Raw Material Market Snapshot
    • 9.5.1. Brazil mRNA Synthesis Raw Material Market
    • 9.5.2. Mexico mRNA Synthesis Raw Material Market
  • 9.6. Rest of The World mRNA Synthesis Raw Material Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Moderna, Inc.
    • 10.2.3. BioNTech SE
    • 10.2.4. Bayer AG
    • 10.2.5. GlaxoSmithKline
    • 10.2.6. Boehringer Ingelheim
    • 10.2.7. CureVac
    • 10.2.8. Sarepta Therapeutics
    • 10.2.9. Alnylam Pharmaceuticals
    • 10.2.10. Ionis Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption